To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.

NCT ID: NCT02213120

Last Updated: 2015-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The VERTIGO study is likely to help determine characteristics of different types of vertigo in patients presenting in the Ear Nose \& Throat (ENT) clinics with complaints of dizziness. Moreover, it will also help to develop an understanding about the current management practices of this condition at local level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vertigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dizziness

Patients with Dizziness

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female patients 18 years of age and older
* Patients with vestibular vertigo of known or unknown origin
* Patients who are willing and able to provide written informed consent

Exclusion Criteria

* Patients with any condition which, in the opinion of the investigator, makes the patient unsuitable for inclusion based on clinical judgment
* Patient with psychiatric disorders, significant neurological disorder or spinal cord damage that would make the evaluation difficult for the investigator
* Patients who are not willing to give informed consent
* Patients with a known history of hypersensitivity to betahistine
* Patients with a history of pheochromocytoma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dimension Research

INDUSTRY

Sponsor Role collaborator

Abbott

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Raeefuddin Ahmed, MD

Role: STUDY_DIRECTOR

Abbott

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research facility ID ORG-001139

Hyderābād, , Pakistan

Site Status

Research facility ID ORG-001053

Islamabad, , Pakistan

Site Status

Research facility ID ORG-001070

Karachi, , Pakistan

Site Status

Research facility ID ORG-001051

Karachi, , Pakistan

Site Status

Research facility ID ORG-001069

Karachi, , Pakistan

Site Status

Research facility ID ORG-001050

Karachi, , Pakistan

Site Status

Research facility ID ORG-001060

Lahore, , Pakistan

Site Status

Research facility ID ORG-001054

Lahore, , Pakistan

Site Status

Research facility ID ORG-001055

Lahore, , Pakistan

Site Status

Research facility ID ORG-001061

Lahore, , Pakistan

Site Status

Research facility ID ORG-001052

Peshawar, , Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BETA5003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of V0251 in Acute Vertigo
NCT01583738 COMPLETED PHASE2
Ménière's Disease Registry
NCT04438538 COMPLETED